ScholarIQanswers from OpenAlex
James Madison University
InstitutionResearch output, impact & collaborations
James Madison University is a institution indexed in ScholarIQ from OpenAlex.
What is known about James Madison University?
ScholarIQrecord summary
James Madison University is a research organisation in Harrisonburg, US. OpenAlex records 15,046 works and 483,126 citations for it. 3,680 researchers list it as their most recent affiliation.
How many works does James Madison University have?
ScholarIQindexed works
James Madison University has 15,046 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James Madison University have?
ScholarIQcitation count
James Madison University has 483,126 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at James Madison University?
ScholarIQresearcher count
James Madison University has 3,680 researchers in the ScholarIQ index.
What is the average h-index at James Madison University?
ScholarIQavg h-index
James Madison University has an average h-index of 82.6 in OpenAlex.
What is the ROR of James Madison University?
ScholarIQror
The ROR for James Madison University is on the source record.
What is the OpenAlex record for James Madison University?
ScholarIQopenalex
The OpenAlex for James Madison University is on the source record.
What is the Wikidata of James Madison University?
ScholarIQwikidata
The Wikidata for James Madison University is on the source record.
Who are the most-cited researchers behind James Madison University?
ScholarIQtop researchers by citations
2
S. Colafranceschi · Particle physics theoretical and experimental studies
1,254 works88,270 citationsWhat are the most-cited papers on James Madison University?
ScholarIQmost cited works
Aortic Pulse Wave Velocity Improves Cardiovascular Event Prediction
Yoav Ben‐Shlomo, Melissa Spears, Chris Boustred, Margaret May, Simon Anderson, Emelia J. Benjamin, Pierre Boutouyrie, James D. Cameron, Chen-Huan Chen, J. CRUICKSHANK, Shih-Jen Hwang, Edward G. Lakatta, Stéphane Laurent, João Maldonado, Gary F. Mitchell, Samer S. Najjar, Anne B. Newman, Mitsuru Ohishi, Bruno Pannier, Telmo Pereira, Ramachandran S. Vasan, Tomoki Shokawa, Kim Sutton-Tyrell, Francis Verbeke, Kang-Ling Wang, David J. Webb, Tine W. Hansen, Sophia Zoungas, Carmel M. McEniery, John R. Cockcroft, Ian B. Wilkinson
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Adam Trickey, Margaret May, Jörg Janne Vehreschild, Niels Obel, M. John Gill, Heidi M. Crane, Christoph Boesecke, Sophie Patterson, Sophie Grabar, Charles Cazanave, Matthias Cavassini, Leah Shepherd, Antonella d’Arminio Monforte, Ard van Sighem, M. S. Saag, Fiona Lampe, Vicky Hernando, Marta Montero, Robert Zangerle, Amy C. Justice, Timothy R. Sterling, Suzanne M Ingle, Jonathan A C Sterne
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
Julia Hippisley‐Cox, Carol Coupland, Yana Vinogradova, John Robson, Margaret May, Peter Brindle
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
C. Warren Olanow, Karl Kieburtz, Per Odin, Alberto J. Espay, David G. Standaert, Hubert H. Fernandez, Arvydas Vanagunas, Ahmed A. Othman, Katherine L. Widnell, Weining Robieson, Yili Pritchett, Krai Chatamra, Janet Benesh, Robert Lenz, Angelo Antonini
Technology in Parkinson's disease: Challenges and opportunities
Alberto J. Espay, Paolo Bonato, Fatta B. Nahab, Walter Maetzler, John Mark Dean, Jochen Klucken, Bjoern M. Eskofier, Aristide Merola, Fay B. Horak, Anthony E. Lang, Ralf Reilmann, J.P. Giuffrida, Alice Nieuwboer, Malcolm Horne, Max A. Little, Irene Litvan, Tanya Simuni, E. Ray Dorsey, Michelle A. Burack, Ken Kubota, Anita Kamondi, Catarina Godinho, Jean‐François Daneault, Georgia Mitsi, Lothar Krinke, Jeffery M. Hausdorff, Bastiaan R. Bloem, Spyros Papapetropoulos, on behalf of the Movement Disorders Society Task Force on Technology
How much of the research on James Madison University is open access?
ScholarIQopen access share
92%OPEN ACCESS